Imaavy

Active Ingredient(s): Nipocalimab-aahu
FDA Approved: * April 29, 2025
Pharm Company: * JANSSEN BIOTECH
Category: Immunosuppressive
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Imaavy 185 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 57894-800
Labeler:
Janssen Biotech, Inc.
Imaavy 185 mg/ml Intravenous Injection, Solution, Concentrate
NDC: 57894-801
Labeler:
Janssen Biotech, Inc.